First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression

NCT06258291 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Septic Shock

Interventions

DEVICE: Hemosystem REBOOT

Sponsor

hemotune AG